期刊文献+

造血系统肿瘤WT1基因启动子区域DNA甲基化及其调控的研究 被引量:3

Study on DNA methylation status of WT1 gene in its promoter region in hematologic malignancy cell lines
原文传递
导出
摘要 目的应用聚合酶链反应(PCR)的实验方法研究白血病细胞系中WT1基因启动子区域的DNA甲基化水平,及其与WT1基因表达的关系。方法①采用RT-PCR技术及甲基化特异性PCR(Methylation-specific PCR,MSP)技术检测8226、HL-60、Jurkat、KG-1及Raji等血液系统肿瘤细胞系中WT1基因mRNA表达水平及其启动子区域的DNA甲基化状态;②以5-杂氮脱氧胞嘧啶(5-aza-CdR)对U937细胞系进行去甲基化处理,并观察WT1基因表达水平的改变。结果①HL-60、K562、KG-1、NB4及SHI-1细胞系中WT1表达水平高,而8226、Jurkat、Raji、U266和U937细胞系WT1表达水平则极低,同时检测到在8226、Jurkat、Raji、U266和U937这5个细胞系存在WT1基因启动子区域DNA高甲基化;②经去甲基化处理后,U937细胞系的WT1基因表达水平较未处理者上升,同时伴随着WT1启动子区域DNA甲基化水平的下降和未甲基化水平的升高。结论WT1基因启动子区域DNA高甲基化是抑制其表达的机制之一。 Objective To study the DNA methylation status of WT1 gene promoter region in hematologic malignancy cell lines and its correlatiou with WT1 gene expression. Methods ①RT-PCR and methvlation-specific PCR were performed for detecting WT1 gene expression and DNA methylation status in its prorooter region in 8226, HL-60, Jurkat, K562, KG-1, NB4, Raji, SHI-1, U266 and U937 cell lines. ②Treatment of U937 cells with 5-aza-CdR, a demethvlation inducing agent and the changes in WTI gene expression level and its promoter regioti methylation status were determined. Results ①HL-60, K562, KG-1, NB4 and SHI-1 cells showed higher levels while 8226, Jurkat, Raji, U266 and U937 cells showed extremely low levels of WT1 expression. DNA hypermethylatil,n in WT1 gene promoter region was ideutified in 8226, Jurkat, Rajl, U266 and U937 cells. ②The WT1 gene expression in U937 was enhanced after treatmeut with 5- aza-CdR accompanied with the decrease of methylated and the increase of unmethylated levels in its promoter region. Conclusion Modulation of the DNA methytation status in WT1 promoter region is one of the epigenetic mechanisms for regulating its expression.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2005年第9期517-520,共4页 Chinese Journal of Hematology
基金 国家自然科学基金资助项目(39770306) 江苏省自然科学基金资助项目(BK97166)
  • 相关文献

参考文献16

  • 1Wang ZY, Qiu QQ, Deuel TF. The Wilms' tumor gene product WT1activates of suppresses transcription through separate functional domains. J Biol Chem, 1993, 268: 9172-9175.
  • 2Reddy JC, Hosono S, Licht JD. The transcriptional effect of WT1 is modulated by choice of expression vector. J Biol Chem, 1995, 270:29976-29982.
  • 3Reddy JC, Licht JD. The WT1 Wilms' tumor suppressor gene: how much do we really know? Biochem Biophys Acta, 1996,1287: 1-28.
  • 4Miwa H, Beran M, Saunder GF. Expression of the Wilms' tumor gene ( WT1 ) inhuman leukemias. Leukemia, 1992, 6: 405-409.
  • 5Inoue K, Sugiyama H, Ogama H, et al. WT1 as a new prognostic factor and new marker for the detection of minimal residual disease in acute leukemia. Blood, 1994, 84: 3071-3079.
  • 6Tamaki H, Ogama H, Ohyashiki K, et al. The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of MDS.Leukemia, 1999, 13: 393-399.
  • 7Heard E, Clerc P, Avner P. X-chromosome inactivation in mammals. Annu Rev Genet, 1997, 31: 571-610.
  • 8Bartolomei MS, Tilghman SM. Genomic imprinting in mammals. Annu Rev Genet, 1997, 31: 493-525.
  • 9Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res, 1997, 57: 808-811.
  • 10Newell-Price J, Clark AJL, King P. DNA methylation and silencing of gene expression. Trends Endocrinol Metab, 2000, 11: 142-148.

二级参考文献9

  • 1Loeb DM, Sukumar S. The role of WT1 in oncogenesis: tumor suppressor or oncogene?Int J Hematol, 2002, 76:117-126.
  • 2Algar E. A Review of the Wilms' tumor 1 gene (WTI) and its role in hematopoiesis and leukemia.J Hematother Stem Cell Res, 2002, 11:589-599.
  • 3Reddy JC, Licht JD. The WTI Wilms' tumor suppressor gene:how much do we really know? Biochim Biophys Acta, 1996,1287: 1-2.
  • 4Svedberg H, Chylicki K, Baldetorp B, et al. Constitutive expression of the Wilms' tumor gene(WT1)in the leukemic cell line U937 blocks parts of the differentiation program .Oncogene, 1998, 16: 925-932.
  • 5James GH, Jeremy RG, Sanna M, et al. Mehtylation-specific PCR assay for methylation status of CpG islands. Proc Nail Acad Sci U S A, 1996,93: 9821-9826.
  • 6Desiderato L, Davey MW, Piper AA. Demethylation of the human MDR1 5' region accompanies activation of P-glycoprotein expression in HL60 multidrug resistant subline.Somat Cell Mol Gene,1997, 23:391-400.
  • 7Issa JP, Baylin SB, Herman JG. DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia,1997,Suppl 1: 7-11.
  • 8Issa JP, Baylin SB, Herman JG, et al. Histone deacetylase 1 inactivation by an adenovirus early gene product.Curr Biol , 2002, 12:594-598.
  • 9Gollnick P, Babitzke P. Transcription attenuation. Biochim Biophys Acta, 2002, 1577: 240-250.

共引文献1

同被引文献46

  • 1Barra JL, Holmes AM, Gregoire A, et al. Novel relationships among DNA methylation, histone modifications and gene expression in Ascobolus[J]. Mol Microbiol, 2005,57(1):180.
  • 2David ML, Ella E, Chirag BP, et al. Wilms'tumor suppressor gene(WT1) is expressed in primary breast tumors despite tumor specific promoter methylation [J]. Cancer Res,2001,61:921.
  • 3Beillard E, Pallisgaard N, van der Velden VHJ, et al. Evaluation of candidate control genes for diagnosis and residual disease detectionin leukemic patients using realtime quantitative reverse transcriptase polymerase chain reaction(FQPCR)-a Europe against cancer program[J].Leukemia, 2003,17 (12) : 2474.
  • 4Ogawa H,Tamaki H, Ikegame K, et al. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia [J].Blood, 2003, 101:1698.
  • 5Messing A, Brenner M. GFAP: Functional implications gleaned from studies of genetically engineered mice[J]. Glia,2003,43(1) :87.
  • 6Kaneuchi M, Sasaki M, Tanaka Y, et al. WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear celt adenocarcinoma[J]. Cancer, 2005,104 ( 9 ) : 1924.
  • 7Shichishima T,Okamoto M,Ikeda K,et al.HLA class II haplo-type and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria.Blood,2002,100;22-28.
  • 8Loeb DM,Evron E,Patel CB,et al.Wilms' tumor suppressor gene(WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.Cancer Res,2001,61:921-925.
  • 9Goldberg AD,Allis CD,Bernstein E.Epigenetics:a landscape takes shape[J].Cell,2007,128(4):635-638.
  • 10Bird A.DNA methylation patterns and epigenetic memory[J].Genes Dev,2002,16(1):6-21.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部